Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Riva, Nicoletta ^a   Ageno, Walter ^a   Poli, Daniela ^b   Testa, Sophie ^c   Rupoli, Serena ^d   Santoro, Rita ^e   Lerede, Teresa ^f   Piana, Antonietta ^g   Carpenedo, Monica ^h   Nicolini, Alberto ^h   Ferrini, Piera Maria ⁱ   Martini, Giuliana ^j   Mangione, Catello ^k   Contino, Laura ^l   Bonfanti, Carlo ^m   Gresele, Paolo ⁿ   Tosetto, Alberto ^o  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Haemostasis and Thrombosis Centre   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e PUGLIESE CIACCIO HOSPITAL   (Italy)

^f PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h Department of Hematology and Transplant Unit AO San Gerardo ^*  (Italy)

ⁱ UO Chirurgia d' Urgenza   (Italy)

^j SPEDALI CIVILI   (Italy)

^k Ospedale Di Galatina   (Italy)

^l C Arrigo Children's Hospital   (Italy)

^m CARLO POMA HOSPITAL   (Italy)

ⁿ UNIVERSITY OF PERUGIA   (Italy)

^o SAN BORTOLO HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ABDOMINAL INFECTION; ABDOMINAL SURGERY; ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; GENE MUTATION; HORMONAL THERAPY; HUMAN; INFLAMMATORY BOWEL DISEASE; KIDNEY VEIN THROMBOSIS; LIVER CIRRHOSIS; LIVER VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN THROMBOSIS; MYELOPROLIFERATIVE NEOPLASM; PORTAL VEIN THROMBOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOLID TUMOR; SPLANCHNIC VEIN THROMBOSIS; SPLENIC VEIN; TREATMENT DURATION; TREATMENT WITHDRAWAL; VEIN THROMBOSIS;

EID: 84945392649     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/620217     Document Type: Article

References (14)

1. I. Martinelli and V. De Stefano, "Rare thromboses of cerebral, splanchnic and upper-extremity veins: a narrative review, " Trombosis and Haemostasis, vol. 103, no. 6, pp. 1136-1144, 2010.
2. F. Dentali, W. Ageno, D. Witt et al., "Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study, " Trombosis and Haemostasis, vol. 102, no. 3, pp. 501-504, 2009.
3. M. R. Tatipelli, R. D. McBane, D. O. Hodge, and W. E. Wysokinski, "Survival and recurrence in patients with splanchnic vein thromboses, " Clinical Gastroenterology and Hepatology, vol. 8, no. 2, pp. 200-205, 2010.
4. B. Condat, F. Pessione, S. Hillaire et al., "Current outcome of portal vein thrombosis in adults: risk and beneft of anticoagulant therapy, " Gastroenterology, vol. 120, no. 2, pp. 490-497, 2001.
5. N. Riva, F. Dentali, M. P. Donadini, A. Squizzato, and W. Ageno, "Risk of recurrence of unusual site venous thromboembolism, " Hamostaseologie, vol. 33, no. 3, pp. 225-231, 2013.
6. C. Kearon, E. A. Akl, A. J. Comerota et al., "Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, " Chest, vol. 141, no. 2, supplement, pp. e419-e494, 2012.
7. W. Ageno, F. Dentali, M. P. Donadini, and A. Squizzato, "Optimal treatment duration of venous thrombosis, " Journal of Trombosis and Haemostasis, vol. 11, supplement 1, pp. 151-160, 2013.
8. N. Riva, A. Tosetto, W. Ageno et al., "Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter retrospective cohort study, " Blood, vol. 124, no. 21, 2014, abstract 4276.
9. P. A. Harris, R. Taylor, R. Tielke, J. Payne, N. Gonzalez, and J. G. Conde, "Research electronic data capture (REDCap)-A metadata-driven methodology and workfow process for providing translational research informatics support, " Journal of Biomedical Informatics, vol. 42, no. 2, pp. 377-381, 2009.
10. E. von Elm, D. G. Altman, M. Egger et al., "The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies, " Annals of Internal Medicine, vol. 147, pp. 573-577, 2007, Erratum in Annals of Internal Medicine, vol. 148, p. 168, 2008.
11. M. C. W. Spaander, J. Hoekstra, B. E. Hansen, H. R. Van Buuren, F. W. G Leebeek, and H. L. A. Janssen, "Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: efect on new thrombotic events and gastrointestinal bleeding, " Journal of Trombosis and Haemostasis, vol. 11, no. 3, pp. 452-459, 2013.
12. P. Prandoni, F. Noventa, A. Ghirarduzzi et al., "The risk of recurrent venous thromboembolism afer discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism, " Haematologica, vol. 92, no. 2, pp. 199-205, 2007
13. M. G. Delgado, S. Seijo, I. Yepes et al., "Efcacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis, " Clinical Gastroenterology and Hepatology, vol. 10, no. 7, pp. 776-783, 2012.
14. E. Villa, C. Camma, M. Marietta et al., "Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis, " Gastroenterology, vol. 143, no. 5, pp. 1253.e4-1260.e4, 2012.